ResMed shares are reportedly falling, with some outlets indicating a significant decline, while others suggest the stock is trading up. The reason for the movement is unclear, but it may be related to post-earnings scrutiny and analyst assessments of the stock's value. The stock has apparently hit a 52-week low, with some sources suggesting it may be undervalued despite the decline.